| Literature DB >> 27135944 |
Caleb C Roth1,2, Randolph D Glickman3, Gleb P Tolstykh2, Larry E Estlack2, Erick K Moen4, Ibtissam Echchgadda5,2, Hope T Beier6, Ronald A Barnes7, Bennett L Ibey5.
Abstract
Nanosecond electrical pulse (nsEP) exposure activates signaling pathways, produces oxidative stress, stimulates hormone secretion, causes cell swelling and induces apoptotic and necrotic death. The underlying biophysical connection(s) between these diverse cellular reactions and nsEP has yet to be elucidated. Using global genetic analysis, we evaluated how two commonly studied cell types, U937 and Jurkat, respond to nsEP exposure. We hypothesized that by studying the genetic response of the cells following exposure, we would gain direct insight into the stresses experienced by the cell and in turn better understand the biophysical interaction taking place during the exposure. Using Ingenuity Systems software, we found genes associated with cell growth, movement and development to be significantly up-regulated in both cell types 4 h post exposure to nsEP. In agreement with our hypothesis, we also found that both cell lines exhibit significant biological changes consistent with mechanical stress induction. These results advance nsEP research by providing strong evidence that the interaction of nsEPs with cells involves mechanical stress.Entities:
Mesh:
Year: 2016 PMID: 27135944 PMCID: PMC4852903 DOI: 10.1371/journal.pone.0154555
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Blumlein line cuvette-based, 10 ns pulser apparatus.
A) Drawing of the complete 10-ns set up, including the Tektronix ocilloscope, Glassman high voltage power supply and custom contol module for regulating the pressure of SF6 in the spark gap chamber. B) This is an enhanced view of the cuvette and its placement/orientation in regards to the pulser.
Fig 2MTT and Flow data for U937 and Jurkat cells exposed to nsEP.
A) Viability of U937 cells exposed to 100 x 10 ns pulses at 150 kV/cm. The lowest level of viability occurred 24 h post exposure. B) Viability of Jurkat cells exposed to 100 x 10 ns pulses at 150 kV/cm. The lowest level of viability occurred 4 h post exposure. C) Phosphatidylserine (PS) and propidium iodide (PI) expression in U937 cells exposed to 100 x 10 ns pulses at 150 kV/cm. D) Phosphatidylserine (PS) and propidium iodide (PI) expression in Jurkat cells exposed to 100 x 10 ns pulses at 150 kV/cm. Heat shock (exposure of cells to 44°C for 40 min) is a stress (apoptosis) control. Digitonin was the positive (necrotic) control.
Fig 3Volcano plots of significant gene expression.
A) U937 cells exposed to nsEP had 327 genes significantly up-regulated as compared to sham (≥2 log ratio and p-value ≤ 0.05). 225 genes were significantly down regulated (≤-2 log ratio and p-value ≤ 0.05). B) Jurkat cells exposed to nsEP had 215 genes significantly up-regulated as compared to sham (≥2 log ratio and p-value ≤ 0.05). 206 genes were significantly down regulated (≤-2 log ratio and p-value ≤ 0.05).
Top 20 genes up- and down-regulated in U937 cells exposed to nsEP.
| UniGene ID | Gene name | Symbol | Fold change 150kVnsEP vs. sham | p-Value 150kv nsEP vs. sham |
|---|---|---|---|---|
| Hs.446125 | male germ cell-associated kinase | MAK | 4.483 | 0.00081 |
| Hs.155111 | hepatitis A virus cellular receptor 2 | HAVCR2 | 4.453 | 0.00479 |
| Hs.351316 | transmembrane 4 L six family member 1 | TM4SF1 | 4.417 | 0.01954 |
| Hs.154057 | matrix metalloproteinase 19 | MMP19 | 4.122 | 0.00389 |
| Hs.370036 | chemokine (C-C motif) receptor 7 | CCR7 | 4.022 | 0.00779 |
| Hs.551526 | Brain-specific protein p25 alpha | TPPP | 3.991 | 0.00274 |
| Hs.267038 | premature ovarian failure, 1B | POF1B | 3.974 | 0.00078 |
| Hs.369063 | Zic family member 2 | ZIC2 | 3.944 | 0.00019 |
| Hs.351316 | transmembrane 4 L six family member 1 | TM4SF1 | 3.896 | 0.00504 |
| Hs.315369 | aquaporin 4 | AQP4 | 3.886 | 0.00755 |
| Hs.129794 | spermatogenesis associated 12 | SPATA12 | 3.745 | 0.00410 |
| Hs.414795 | serine (or cysteine) proteinase inhibitor, clade E | SERPINE1 | 3.692 | 0.00591 |
| Hs.362807 | interleukin 7 receptor /// interleukin 7 receptor | IL7R | 3.652 | 0.02727 |
| Hs.436298 | epithelial membrane protein 1 | EMP1 | 3.638 | 0.00018 |
| Hs.436550 | Na2+ channel, voltage gated, type VIII, alpha subunit | SCN8A | 3.606 | 0.02903 |
| Hs.504908 | LIM domain only 3 (rhombotin-like 2) | LMO3 | 3.551 | 0.00110 |
| Hs.91791 | Transmembrane protein 16C | TMEM16C | 3.468 | 0.00232 |
| Hs.249718 | eukaryotic translation initiation factor 4E | EIF4E | 3.417 | 0.01264 |
| Hs.514665 | DLGAP1 antisense RNA 2 | DLGAP1-AS2 | 3.404 | 0.00187 |
| Hs.2258 | matrix metallopeptidase 10 (stromelysin 2) | MMP10 | 3.331 | 0.02632 |
| Hs.388715 | small leucine-rich protein 1 | SMLR1 | -3.009 | 0.02216 |
| Hs.433586 | PPP5 tetratricopeptide repeat domain containing 1 | PPP5D1 | -3.032 | 0.00243 |
| Hs.534859 | Kazal-type serine peptidase inhibitor domain 1 | KAZALD1 | -3.066 | 0.00610 |
| Hs.177193 | synaptotagmin IX | SYT9 | -3.082 | 0.00727 |
| Hs.195298 | sarcoglycan, zeta | SGCZ | -3.114 | 0.00341 |
| Hs.549092 | suppression of tumorigenicity 18, zinc finger | ST18 | -3.199 | 0.00272 |
| Hs.322444 | RAMP2 antisense RNA 1 | RAMP2-AS1 | -3.224 | 0.00613 |
| Hs.4290 | RAB3C, member RAS oncogene family | RAB3C | -3.255 | 0.00912 |
| Hs.208544 | potassium channel, subfamily K, member 1 | KCNK1 | -3.273 | 0.00093 |
| Hs.537383 | olfactory receptor, family 5, subfamily H, member 1 | OR5H1 | -3.290 | 0.00431 |
| Hs.549149 | catenin (cadherin-associated protein), alpha 3 | CTNNA3 | -3.323 | 0.03010 |
| Hs.131152 | long intergenic non-protein coding RNA 643 | LINC00643 | -3.372 | 0.02482 |
| Hs.408453 | Wilms tumor 1 | WT1 | -3.440 | 0.00425 |
| Hs.471162 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 | RAPH1 | -3.563 | 0.00105 |
| Hs.274264 | visual system homeobox 1 | VSX1 | -3.633 | 0.00772 |
| Hs.27043 | K+ voltage-gated channel, subfamily H member 5 | KCNH5 | -3.687 | 0.00549 |
| Hs.387367 | cytochrome P450, family 39, subfamily A, polypeptide 1 | CYP39A1 | -3.693 | 0.01892 |
| Hs.147471 | zinc finger protein 749 | ZNF749 | -3.713 | 0.00114 |
| Hs.173536 | protein kinase D3 | PRKD3 | -3.882 | 0.00010 |
| Hs.440722 | zinc finger protein 587 | ZNF417 | -3.996 | 0.00115 |
| Hs.146040 | chromosome 14 open reading frame 105 | C14orf105 | -4.364 | 0.00018 |
Top 20 genes up- and down-regulated in Jurkat cells exposed to nsEP.
| UniGene ID | Gene name | Symbol | Fold change 150kVnsEP vs. sham | p-Value 150kv nsEP vs. sham |
|---|---|---|---|---|
| Hs.25647 | v-fos FBJ murine osteosarcoma viral oncogene homolog | FOS | 7.269 | 0.00031 |
| Hs.326035 | Early growth response 1 | EGR1 | 5.213 | 0.00031 |
| Hs.326035 | early growth response 1 | EGR1 | 4.941 | 0.00029 |
| Hs.549031 | early growth response 4 | EGR4 | 4.472 | 0.00244 |
| Hs.326035 | early growth response 1 | EGR1 | 4.349 | 0.00009 |
| Hs.494326 | basic leucine zipper nuclear factor 1 (JEM-1) | BLZF1 | 4.106 | 0.00281 |
| Hs.1395 | early growth response 2 | EGR2 | 3.981 | 0.02375 |
| Hs.536535 | dual specificity phosphatase 16 | DUSP16 | 3.832 | 0.00036 |
| Hs.529512 | zinc finger protein 167 | ZNF167 | 3.700 | 0.01073 |
| Hs.525704 | v-jun sarcoma virus 17 oncogene homolog | JUN | 3.606 | 0.00257 |
| Hs.195398 | oligodendrocyte transcription factor 3 | OLIG3 | 3.604 | 0.01432 |
| Hs.413099 | glycine receptor, alpha 3 | GLRA3 | 3.579 | 0.03397 |
| Hs.75678 | FBJ murine osteosarcoma viral oncogene homolog B | FOSB | 3.577 | 0.00137 |
| Hs.549086 | discs, large (Drosophila) homolog-associated protein 1 | DLGAP1 | 3.523 | 0.00130 |
| Hs.532933 | purinergic receptor P2Y, G-protein coupled, 12 | P2RY12 | 3.499 | 0.00649 |
| Hs.525704 | v-jun sarcoma virus 17 oncogene homolog | JUN | 3.466 | 0.00004 |
| Hs.519601 | Inhibitor of DNA binding 4, dominant negative helix-loop-helix | ID4 | 3.400 | 0.00024 |
| Hs.56247 | inducible T-cell co-stimulator | ICOS | 3.390 | 0.00468 |
| Hs.162246 | transmembrane protein 171 | TMEM171 | 3.265 | 0.01988 |
| Hs.498513 | aldo-keto reductase family 1, member C2 | AKR1C1/AKR1C2 | 3.232 | 0.00894 |
| Hs.369263 | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) | PDS5B | -3.059 | 0.03108 |
| Hs.24115 | miR-17-92 cluster host gene (non-protein coding) | MIR17HG | -3.098 | 0.04827 |
| Hs.510093 | Abelson helper integration site 1 | AHI1 | -3.113 | 0.00354 |
| Hs.551839 | uncharacterized LOC284600 | LOC284600 | -3.155 | 0.04887 |
| Hs.159234 | forkhead box E1 (thyroid transcription factor 2) | FOXE1 | -3.184 | 0.01954 |
| Hs.271791 | ATR serine/threonine kinase | ATR | -3.186 | 0.00019 |
| Hs.525700 | small nuclear ribonucleoprotein polypeptide N | SNRPN | -3.377 | 0.00003 |
| Hs.371903 | glycophorin E (MNS blood group) | GYPE | -3.398 | 0.01643 |
| Hs.72901 | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | CDKN2B | -3.451 | 0.00363 |
| Hs.2799 | hyaluronan and proteoglycan link protein 1 | HAPLN1 | -3.471 | 0.00454 |
| Hs.44685 | ring finger protein 141 | RNF141 | -3.474 | 0.04947 |
| Hs.549172 | calmodulin-like 4 | CALML4 | -3.495 | 0.00665 |
| Hs.54973 | cadherin 26 | CDH26 | -3.551 | 0.03073 |
| Hs.519523 | serpin peptidase inhibitor, clade B (ovalbumin), member 6 | SERPINB6 | -3.560 | 0.00003 |
| --- | long intergenic non-protein coding RNA 644 | LINC00644 | -3.568 | 0.00450 |
| Hs.76561 | zinc finger protein 404 | ZNF404 | -3.603 | 0.00177 |
| Hs.170849 | coiled-coil domain containing 122 | CCDC122 | -3.614 | 0.00129 |
| Hs.389945 | WD repeat domain 60 | WDR60 | -3.641 | 0.00213 |
| Hs.242520 | uromodulin-like 1 | UMODL1 | -3.680 | 0.01025 |
| Hs.436380 | MAM domain containing glycosylphosphatidylinositol anchor 2 | MDGA2 | -3.703 | 0.02430 |
| Hs.72307 | G protein-coupled receptor 110 | GPR110 | -3.720 | 0.01181 |
Pathway Analysis: Top Molecular Functions.
| Molecular and Cellular Functions | ||
|---|---|---|
| Function | p-values | # of Molecules |
| Cellular Movement | 5.48E-13–1.32E-03 | 455 |
| Cell-To-Cell Signaling and Interaction | 1.95E-11–1.28E-03 | 533 |
| Cellular Development | 4.35E-08–1.28E-03 | 593 |
| Cellular Growth and Proliferation | 9.37E-08–1.28E-03 | 751 |
| Cell Death and Survival | 2.65E-07–1.36E-03 | 734 |
| Cellular Movement | 1.52E-14–1.10E-03 | 429 |
| Cell-To-Cell Signaling and Interaction | 8.03E-08–1.17E-03 | 508 |
| Nucleic Acid Metabolism | 1.23E-07–5.33E-05 | 70 |
| Small Molecule Biochemistry | 1.23E-07–1.10E-03 | 283 |
| Cellular Development | 1.50E-07–1.11E-03 | 575 |
Top Canonical Pathways.
| Canonical Pathway | ||
|---|---|---|
| Function | p-values | # of Molecules |
| VDR/RXR Activation | 4.86E-06 | 33/77 (0.429) |
| B Cell Development | 9.09E-05 | 15/28 (0.536) |
| ILK Signaling | 1.03E-04 | 58/181 (0.32) |
| tRNA Splicing | 1.54E-04 | 17/35 (0.486) |
| Hepatic Fibrosis / Hepatic Stellate Cell Activation | 1.74E-04 | 61/196 (0.311) |
| Hepatic Fibrosis / Hepatic Stellate Cell Activation | 2.9E-06 | 63/196 (0.321) |
| G-Protein Coupled Receptor Signaling | 1.17E-05 | 75/254 (0.295) |
| LPS/IL-1 Mediated Inhibition of RXR Function | 1.2E-05 | 64/208 (0.308) |
| cAMP-mediated signaling | 8.37E-05 | 63/216 (0.292) |
| Atherosclerosis Signaling | 1.62E-04 | 39/120 (0.325) |
Genes up- or down-regulated in common by nsEP exposure in Jurkat and U937 cells.
| Gene Symbol | Gene name | Jurkat Fold Change | p-Value | U937 Fold Change | p-Value |
|---|---|---|---|---|---|
| JUN | jun proto-oncogene | 3.606 | 0.0026 | 2.444 | 0.0001 |
| VEGFA | vascular endothelial growth factor A | 2.594 | 0.0396 | 1.32 | 0.0146 |
| RORA | RAR-related orphan receptor A | 2.569 | 0.0471 | 1.949 | 0.0072 |
| MXD1 | MAX dimerization protein 1 | 2.354 | 0.0095 | 1.635 | 0.0072 |
| ATF3 | activating transcription factor 3 | 2.301 | 0.0005 | 1.216 | 0.0014 |
| PPP1R15A | protein phosphatase 1, regulatory subunit 15A | 2.298 | 0.0032 | 2.21 | 0.0002 |
| NDUFA10 | NADH dehydrogenase (ubiquinone) 1 alpha, 10, 42kDa | 2.286 | 0.0018 | 1.83 | 0.0424 |
| BHLHE40 | basic helix-loop-helix family, member e40 | 2.235 | 0.0338 | 1.253 | 0.0013 |
| LDLR | low density lipoprotein receptor | 2.218 | 0.0096 | 2.463 | 0.0386 |
| NRP2 | neuropilin 2 | 2.082 | 0.0295 | 3.022 | 0.0031 |
| SASH1 | SAM and SH3 domain containing 1 | 2.081 | 0.0000 | 1.768 | 0.0204 |
| TBX3 | T-box 3 | 2.024 | 0.0420 | 2.052 | 0.0060 |
| DOCK4 | dedicator of cytokinesis 4 | 1.942 | 0.0134 | 1.307 | 0.0303 |
| SLC7A11 | solute carrier family 7 member 11 | 1.875 | 0.0041 | 2.309 | 0.0040 |
| ULK2 | unc-51 like autophagy activating kinase 2 | 1.848 | 0.0293 | 1.38 | 0.0177 |
| S1PR3 | sphingosine-1-phosphate receptor 3 | 1.824 | 0.0463 | 1.18 | 0.0047 |
| DUSP10 | dual specificity phosphatase 10 | 1.821 | 0.0046 | 1.571 | 0.0108 |
| CHD2 | chromodomain helicase DNA binding protein 2 | 1.75 | 0.0034 | 1.511 | 0.0231 |
| TSC22D3 | TSC22 domain family, member 3 | 1.729 | 0.0370 | 1.807 | 0.0408 |
| CACNB2 | calcium channel, voltage-dependent, beta 2 subunit | 1.718 | 0.0290 | 2.412 | 0.0409 |
| EYA3 | EYA transcriptional coactivator and phosphatase 3 | 1.613 | 0.0322 | 2.8 | 0.0480 |
| RNA45S5 | RNA, 45S pre-ribosomal 5 | 1.599 | 0.0003 | 2.887 | 0.0009 |
| CREBRF | CREB3 regulatory factor | 1.578 | 0.0267 | 1.092 | 0.0232 |
| RNF31 | ring finger protein 31 | 1.545 | 0.0488 | 1.72 | 0.0123 |
| CAMK2B | calcium/calmodulin-dependent protein kinase II beta | 1.529 | 0.0252 | 1.706 | 0.0387 |
| KLF6 | Kruppel-like factor 6 | 1.473 | 0.0016 | 1.939 | 0.0029 |
| SESN2 | sestrin 2 | 1.463 | 0.0123 | 1.606 | 0.0000 |
| MASP2 | mannan-binding lectin serine peptidase 2 | 1.448 | 0.0179 | 2.265 | 0.0283 |
| ARG1 | arginase 1 | 1.382 | 0.0441 | 1.386 | 0.0430 |
| NPR1 | natriuretic peptide receptor 1 | 1.362 | 0.0080 | 2.291 | 0.0118 |
| TM4SF1 | transmembrane 4 L six family member 1 | 1.349 | 0.0249 | 4.417 | 0.0195 |
| FAM122C | family with sequence similarity 122C | 1.31 | 0.0341 | 1.058 | 0.0162 |
| JUND | jun D proto-oncogene | 1.308 | 0.0042 | 1.733 | 0.0057 |
| SPATA6 | spermatogenesis associated 6 | 1.27 | 0.0237 | 1.924 | 0.0105 |
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 1.142 | 0.0074 | 2.861 | 0.0002 |
| NEU1 | sialidase 1 (lysosomal sialidase) | 1.134 | 0.0296 | 1.201 | 0.0014 |
| CD55 | CD55 molecule, decay accelerating factor for complement | 1.11 | 0.0324 | 1.321 | 0.0062 |
| ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 1.079 | 0.0455 | 1.267 | 0.0052 |
| SKIL | SKI-like proto-oncogene | 1.073 | 0.0026 | 1.554 | 0.0302 |
| HAO2 | hydroxyacid oxidase 2 (long chain) | 1.042 | 0.0494 | 1.618 | 0.0393 |
| MAFF | v-maf avian musculoaponeurotic fibrosarcoma oncogene F | 1.007 | 0.0170 | 1.653 | 0.0022 |
| MEX3D | mex-3 RNA binding family member D | -1.045 | 0.0318 | -2.098 | 0.0012 |
| EBF3 | early B-cell factor 3 | -1.082 | 0.0122 | -1.047 | 0.0403 |
| ZNF205 | zinc finger protein 205 | -1.083 | 0.0039 | -2.33 | 0.0060 |
| PPIL2 | peptidylprolyl isomerase (cyclophilin)-like 2 | -1.123 | 0.0417 | -2.111 | 0.0041 |
| XIRP2 | xin actin-binding repeat containing 2 | -1.19 | 0.0204 | -2.27 | 0.0255 |
| TEX14 | testis expressed 14 | -1.22 | 0.0002 | -1.113 | 0.0242 |
| CLECL1 | C-type lectin-like 1 | -1.23 | 0.0407 | -2.337 | 0.0097 |
| HNRNPD | heterogeneous nuclear ribonucleoprotein D | -1.307 | 0.0083 | -1.545 | 0.0113 |
| GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 | -1.32 | 0.0411 | -1.784 | 0.0319 |
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | -1.38 | 0.0121 | -1.722 | 0.0199 |
| GPR98 | G protein-coupled receptor 98 | -1.515 | 0.0408 | -1.46 | 0.0232 |
| SATB1 | SATB homeobox 1 | -1.97 | 0.0350 | -1.548 | 0.0003 |
| RERE | arginine-glutamic acid dipeptide (RE) repeats | -2.105 | 0.0373 | -2.224 | 0.0488 |
| FERMT1 | fermitin family member 1 | -2.548 | 0.0123 | -1.4 | 0.0182 |
| TSEN54 | TSEN54 tRNA splicing endonuclease subunit | -2.707 | 0.0058 | -1.638 | 0.0389 |
| PHLPP1 | PH domain and leucine rich repeat protein phosphatase 1 | -2.862 | 0.0066 | -1.037 | 0.0132 |
| HAPLN1 | hyaluronan and proteoglycan link protein 1 | -3.471 | 0.0045 | -2.922 | 0.0221 |
Fig 4Scatter dot plot for each qRT-PCR validation sample.
A) Comparison of the expression levels of JUN for U937 cells exposed to nsEP. B) Comparison of the expression levels of JUN for Jurkat cells exposed to nsEP. C) Comparison of the expression levels of DUSP10 for U937 cells exposed to nsEP. D) Comparison of the expression levels of DUSP10 for Jurkat cells exposed to nsEP. E) Comparison of the expression levels of HPRT1 for U937 cells exposed to nsEP. F) Comparison of the expression levels of HPRT1 for Jurkat cells exposed to nsEP. Mean and standard deviation are plotted as the green and black lines respectively.
Fig 5Levels of MAP Kinase associated proteins post nsEP exposure for U937 and Jurkat Cells.
A) Levels of MAPK proteins for U937 at 4 h post exposure. B) Levels of MAPK proteins for Jurkat at 4 h post exposure. C) Levels of MAPK proteins for U937 at 8 h post exposure. D) Levels of MAPK proteins for Jurkat at 8 h post exposure. E) Levels of MAPK proteins for U937 at 12 h post exposure. F) Levels of MAPK proteins for Jurkat at 12 h post exposure. Error bars represent standard deviation (SD).
Fig 6Oxidative stress related protein levels in U937 and Jurkat cells exposed to nsEP.
A) Levels of oxidative stress proteins for U937 at 4 h post exposure. B) Levels of oxidative stress proteins for Jurkat at 4 h post exposure. C) Levels of oxidative stress proteins for U937 at 8 h post exposure. D) Levels of oxidative stress proteins for Jurkat at 8 h post exposure. E) Levels of oxidative stress proteins for U937 at 12 h post exposure. F) Levels of oxidative stress proteins for Jurkat at 12 h post exposure. Error bars represent standard deviation (SD).
Mechanical stress-associated genes Up-Regulated by nsEP.
| Gene Name | Symbol | Function (from NCBI Resources: Gene) | Cell |
|---|---|---|---|
| male germ cell-associated kinase | MAK | serine/threonine protein kinase related to kinases involved in cell cycle regulation | U937 |
| v-jun sarcoma virus 17 oncogene homolog | JUN | interacts directly with specific target DNA sequences to regulate gene expression, part of the JNK pathway | U937/ Jurkat |
| FBJ murine osteosarcoma viral oncogene homolog | FOS | regulator of cell proliferation, differentiation, and transformation. | Jurkat |
| Early Growth Response 1 | EGR1 | induces the expression of growth factors, growth factor receptors, extracellular matrix proteins, proteins involved in the regulation of cell growth or differentiation, and proteins involved in apoptosis, growth arrest, and stress responses | Jurkat |
| Early Growth Response 4 | EGR4 | cell proliferation by increased expression of potassium chloride cotransporter 2b (KCC2b) | Jurkat |
| basic leucine zipper nuclear factor 1 | BLZF1 | regulation of cell growth | Jurkat |
| Early Growth Response 2 | EGR2 | mediates NFκB and MAPK signaling | Jurkat |
| dual specificity phosphatase 10 | DUSP10 | regulates the c-Jun amino-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) pathways | U937 Jurkat |
| dual specificity phosphatase 16 | DUSP16 | regulates the c-Jun amino-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) pathways | Jurkat |
| flavin containing monooxygenase 3 | FMO3 | transmembrane protein localizes to the endoplasmic reticulum | U937 |
| transmembrane 4 L six family member 1 | TM4SF1 | molecular organizer that interacts with membrane and cytoskeleton-associated proteins | U937 |
| matrix metalloproteinase 19 | MMP19 | breakdown of extracellular matrix | U937 |
| premature ovarian failure, 1B | POF1B | binds non-muscle actin filaments | U937 |
| Brain-specific protein p25 alpha | TPPP | binds to tubulin and microtubules and induces aberrant microtubule assemblies | U937 |
| aquaporin 4 | AQP4 | function as water-selective channels in the plasma membranes | U937 |
| Anoctamins | TMEM16C | phospholipid scrambling | U937 |
| matrix metalloproteinase 10 (stromelysin 2) | MMP10 | breakdown of extracellular matrix | U937 |
| Annexin A1 | ANXA1 | membrane-localized protein that binds phospholipids | U937 |
| glycine receptor, alpha 3 | GLRA3 | encodes a member of the ligand-gated ion channel protein family | Jurkat |
| chemokine (C-C motif) receptor 7 | CCR7 | member of the G protein-coupled receptor family | U937 |
| regulator of G-protein signaling 1 | RGS1 | attenuates the signaling activity of G-proteins by binding to activated, GTP-bound G alpha subunit | U937 |
| polycystic kidney disease 1 like 1 | PKD1L1 | novel G-protein-binding protein. Ca2+-permeable pore-forming subunits and receptor-like integral membrane proteins | U937 |
| purinergic receptor P2Y, G-protein coupled, 12 | P2RY12 | belongs to the family of G-protein coupled receptor | Jurkat |